KARUS THERAPEUTICS
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.
KARUS THERAPEUTICS
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2005-01-01
Address:
Chilworth, Hampshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.karustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
44-(0)2380-111-360
Email Addresses:
[email protected]
Total Funding:
14.75 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail ASP.NET IIS IIS 8 Network Solutions DNS Sophos
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Current Advisors List
Current Employees Featured
Founder
Investors List
SV Health Investors
SV Health Investors investment in Series B - Karus Therapeutics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Karus Therapeutics
IP Group
IP Group investment in Series B - Karus Therapeutics
SV Health Investors
SV Health Investors investment in Series B - Karus Therapeutics
International Biotechnology Trust
International Biotechnology Trust investment in Series B - Karus Therapeutics
Novo Holdings
Novo Holdings investment in Series B - Karus Therapeutics
Esperante Ventures
Esperante Ventures investment in Venture Round - Karus Therapeutics
IP Group
IP Group investment in Venture Round - Karus Therapeutics
New Hill Management
New Hill Management investment in Venture Round - Karus Therapeutics
Angels 5K
Angels 5K investment in Seed Round - Karus Therapeutics
Official Site Inspections
http://www.karustherapeutics.com
- Host name: 96-126-111-165.ip.linodeusercontent.com
- IP address: 96.126.111.165
- Location: Newark United States
- Latitude: 40.739
- Longitude: -74.1697
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07175
More informations about "Karus Therapeutics"
Karus Therapeutics - Crunchbase Company Profile
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.See details»
Karus Therapeutics 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Karus Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Karus Therapeutics Ltd. - Drug pipelines, Patents, …
Jun 15, 2025 Oxfordshire, UK, 27 April 2020 – Karus Therapeutics Ltd (‘Karus’), a clinical-stage biopharmaceutical company developing precision medicines for cancer, announces that new data will be presented from its KA2507 Phase I …See details»
Karus Therapeutics Ltd - Harwell Campus
Karus is a leader in the design and development of innovative cancer therapeutics. Our orally-active, small molecule drugs combine targeted cancer cell activity with immunotherapy for the …See details»
Karus Therapeutics - 2025 Company Profile - Tracxn
Karus Therapeutics is a deadpooled company based in Abingdon (United Kingdom), founded in 2005. It operates as a Developer of oral small molecule inhibitors to treat multiple diseases. …See details»
Karus Therapeutics - VentureRadar
Karus Therapeutics is a leader in the development of innovative medicines that have breakthrough potential in treating inflammatory disease and cancer. The Company's scientific …See details»
Karus Therapeutics Ltd - Company Profile and News
Company profile page for Karus Therapeutics Ltd including stock price, company news, executives, board members, and contact informationSee details»
Karus Therapeutics - VentureRadar
"Karus Therapeutics is a leader in the development of innovative medicines that have breakthrough potential in treating inflammatory disease and cancer. The Company's scientific …See details»
Karus Therapeutics Company Profile - Office Locations ... - Craft
Karus Therapeutics has 5 employees at their 1 location. See insights on Karus Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Karus Therapeutics - Profile
Karus Therapeutics, based in Oxfordshire, UK, is a clinical-stage biopharmaceutical company developing precision medicines for cancer. The Company’s orally-active, small molecule drugs …See details»
KARUS THERAPEUTICS LIMITED overview - Find and update …
Nov 9, 2024 KARUS THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, …See details»
Organization | Karus Therapeutics Limited
Karus Therapeutics Limited Report issue For profit Phase 1 Phase 2 Founded: Chilworth United Kingdom (2005) Organization Overview First Clinical Trial 2016 NCT02679196 First Marketed …See details»
Karus Therapeutics company information, funding & investors
Jun 1, 2005 Karus Therapeutics, clinical-stage biopharmaceutical company, based in oxfordshire, uk. Here you'll find information about their funding, investors and team.See details»
Karus Therapeutics: Revenue, Worth, Valuation & Competitors 2025
About Karus Therapeutics Karus Therapeutics is a Biotech related company with 5 employees an estimated revenue of $775K, and. It has 10 competitors including Dermavant Sciences, …See details»
Karus Therapeutics Ltd. - BioCentury Company Profiles - BCIQ
Jan 4, 2023 Karus Therapeutics Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Karus Therapeutics - Profiles & Contacts - Crunchbase
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.See details»
Karus | Chemistry | University of Southampton
Karus A spin-out collaboration co-founded by Chemistry's Dr Ganesan and researchers based within Medicine for Cancer Research UK, Karus Therapeutics investigates the biological …See details»
KARUS THERAPEUTICS LIMITED - Companies House
KARUS THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Karus Therapeutics - Funding, Financials, Valuation & Investors
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.See details»
Karus Therapeutics Announces New Data from Phase I Cancer Trial …
Oxfordshire, UK, 27 April 2020 – Karus Therapeutics Ltd (‘Karus’), a clinical-stage biopharmaceutical company developing precision medicines for cancer, announces that new …See details»